Levosimendan Injection

[Specification] 5ml: 12.5 mg

[Indications] Levosimendan Injection is used in authorized markets for the short-term treatment of acutely decompensated severe chronic heart failure in situations where conventional therapy is insufficient and inotropic support is considered appropriate. The exact indication depends on the applicable approved product information.

[Usage and dosage] Levosimendan is administered by intravenous infusion under specialist supervision with continuous monitoring of blood pressure, heart rate, ECG, and fluid status. The loading dose, infusion rate, and treatment duration must be determined according to the current approved product information and the patient's hemodynamic status. A specific regimen should not be published until the applicable official label has been verified.